Activin A induces dendritic cell migration through the polarized release of CXC chemokine ligands 12 and 14

Blood

Volumn 113, Issue 23, 2009, Pages 5848-5856

  Salogni, Laura ^a   Musso, Tiziana ^b   Bosisio, Daniela ^a   Mirolo, Massimiliano ^c   Jala, Venkatakrishna R ^d   Haribabu, Bodduluri ^d   Locati, Massimo ^c   Sozzani, Silvano ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,6 DIHYDROXYHEXYL) 6 (3 HYDROXY 1,5 UNDECADIENYL)PYRIDINE; 4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ACTIVIN A; ALPHA CHEMOKINE; COMPLEMENTARY DNA; CXCL14 CHEMOKINE; CYCLOHEXIMIDE; CYTOKINE; GINKGOLIDE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; LEUKOTRIENE B4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCLONAL ANTIBODY; PERTUSSIS TOXIN; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1; THROMBOCYTE ACTIVATING FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ACTIVIN; CXCL12 PROTEIN, HUMAN; CXCL12 PROTEIN, MOUSE; CXCL14 PROTEIN, HUMAN; CXCL14 PROTEIN, MOUSE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; ANIMAL; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG EFFECT; METABOLISM; MOUSE; TIME; UPREGULATION;

ACTIVINS; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL12; CHEMOKINES, CXC; DENDRITIC CELLS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; MICE; TIME FACTORS; UP-REGULATION;

EID: 67651097892     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-12-194597     Document Type: Article

References (43)

1. Kretzschmar M, Massague J. SMADs: mediators and regulators of TGF-β signaling. Curr Opin Genet Dev. 1998;8:103-111. (Pubitemid 28122148)
2. Phillips DJ, Jones KL, Clarke IJ, Scheerlinck JP, de Kretser DM. Activin A: from sometime reproductive factor to genuine cytokine. Vet Immunol Immunopathol. 2005;108:23-27.
3. Scutera S, Riboldi E, Daniele R, et al. Production and function of activin A in human dendritic cells. Eur Cytokine Network. 2008;19:60-68.
4. Werner S, Alzheimer C. Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine Growth Factor Rev. 2006;17:157-171. (Pubitemid 43816894)
5. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767-811.
6. Macagno A, Napolitani G, Lanzavecchia A, Sallusto F. Duration, combination and timing: the signal integration model of dendritic cell activation. Trends Immunol. 2007;28:227-233. (Pubitemid 46654873)
7. Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol. 2006;311:17-58. (Pubitemid 47413194)
8. Sozzani S. Dendritic cell trafficking: more than just chemokines. Cytokine Growth Factor Rev. 2005;16:581-592. (Pubitemid 41505518)
9. Randolph GJ, Angeli V, Swartz MA. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol. 2005;5:617-628. (Pubitemid 41113193)
10. Robson NC, Phillips DJ, McAlpine T, et al. Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production. Blood. 2008;111:2733-2743.
11. Musso T, Scutera S, Vermi W, et al. Activin A induces Langerhans cell differentiation in vitro and in human skin explants. PLoS ONE. 2008;3:e3271.
12. Hubner G, Brauchle M, Gregor M, Werner S. Activin A: a novel player and inflammatory marker in inflammatory bowel disease? Lab Invest. 1997;77:311-318.
13. Fumagalli M, Musso T, Vermi W, et al. Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin. Exp Dermatol. 2007;16:600-610. (Pubitemid 46958566)
14. Stoitzner P, Stossel H, Wankell M, et al. Langerhans cells are strongly reduced in the skin of transgenic mice overexpressing follistatin in the epidermis. Eur J Cell Biol. 2005;84:733-741. (Pubitemid 41149296)
15. van Berkel V, Barrett J, Tiffany HL, et al. Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J Virol. 2000;74:6741-6747. (Pubitemid 30470656)
16. Sozzani S, Sallusto F, Luini W, et al. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J Immunol. 1995;155:3292-3295.
17. Del Prete A, Vermi W, Dander E, et al. Defective dendritic cell migration and activation of adaptive immunity in PI3Kγ-deficient mice. EMBO J. 2004;23:3505-3515. (Pubitemid 39265540)
18. Zozulya AL, Reinke E, Baiu DC, Karman J, Sandor M, Fabry Z. Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases. J Immunol. 2007;178:520-529. (Pubitemid 46033636)
19. Mili S, Moissoglu K, Macara IG. Genome-wide screen reveals APC-associated RNAs enriched in cell protrusions. Nature. 2008;453:115-119. (Pubitemid 351630332)
20. Opdenakker G, Van den Steen PE, Van Damme J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol. 2001;22:571-579.
21. Reibman J, Meixler S, Lee TC, et al. Transforming growth factor beta1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways. Proc Natl Acad Sci U S A. 1991;88:6805-6809. (Pubitemid 21915038)
22. Sozzani S, Molino M, Locati M, et al. Receptor-activated calcium influx in human monocytes exposed to monocyte chemotactic protein-1 and related cytokines. J Immunol. 1993;150:1544-1553. (Pubitemid 23127446)
23. Nusing RM, Barsig J. Induction of prostanoid, nitric oxide, and cytokine formation in rat bone marrow derived macrophages by activin A. Br J Pharmacol. 1999;127:919-926. (Pubitemid 29295351)
24. Ali H, Richardson RM, Haribabu B, Snyderman R. Chemoattractant receptor cross-desensitization. J Biol Chem. 1999;274:6027-6030.
25. Incorvaia L, Badalamenti G, Rini G, et al. MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone. Anticancer Res. 2007;27:1519-1525.
26. Caniggia I, Lye SJ, Cross JC. Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinology. 1997;138:3976-3986. (Pubitemid 27351954)
27. Jones RL, Stoikos C, Findlay JK, Salamonsen LA. TGF-beta superfamily expression and actions in the endometrium and placenta. Reproduction. 2006;132:217-232. (Pubitemid 44269704)
28. Parekh T, Saxena B, Reibman J, Cronstein BN, Gold LI. Neutrophil chemotaxis in response to TGF-β isoforms (TGF-beta1, TGF-beta2, TGF-beta3) is mediated by fibronectin. J Immunol. 1994;152:2456-2466. (Pubitemid 24097938)
29. Agace WW, Amara A, Roberts AI, et al. Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation. Curr Biol. 2000;10:325-328. (Pubitemid 30186136)
30. Wright N, de Lera TL, Garcia-Moruja C, et al. Transforming growth factor-β1 down-regulates expression of chemokine stromal cell-derived factor-1: functional consequences in cell migration and adhesion. Blood. 2003;102:1978-1984. (Pubitemid 37122369)
31. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol Today. 1999;20:254-257. (Pubitemid 29258161)
32. Chen B, Chou TH, Sensenbrenner L. Induction of murine peritoneal macrophage colony-forming cells by peritoneal administration of macrophage inflammatory protein-1alpha. Exp Hematol. 1993;21:1591-1596. (Pubitemid 24216801)
33. McCain RW, Dessypris EN, Christman JW. Granulocyte/Macrophage colony-stimulating factor stimulates human polymorphonuclear leukocytes to produce interleukin-8 in vitro. Am J Respir Cell Mol Biol. 1993;8:28-34.
34. Wempe F, Lindner V, Augustin HG. Basic fibroblast growth factor (bFGF) regulates the expression of the CC chemokine monocyte chemoattractant protein-1 (MCP-1) in autocrine-activated endothelial cells. Arterioscler Thromb Vasc Biol. 1997;17:2471-2478. (Pubitemid 28015983)
35. Chen Y, Corriden R, Inoue Y, et al. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science. 2006;314:1792-1795. (Pubitemid 44969094)
36. Bagorda A, Parent CA. Eukaryotic chemotaxis at a glance. J Cell Sci. 2008;121:2621-2624.
37. Tannetta DS, Muttukrishna S, Groome NP, Redman CW, Sargent IL. Endothelial cells and peripheral blood mononuclear cells are a potential source of extraplacental activin A in preeclampsia. J Clin Endocrinol Metab. 2003;88:5995-6001. (Pubitemid 38033084)
38. Birdsall M, Ledger W, Groome N, Abdalla H, Muttukrishna S. Inhibin A and activin A in the first trimester of human pregnancy. J Clin Endocrinol Metab. 1997;82:1557-1560. (Pubitemid 27200434)
39. Rabinovici J, Goldsmith PC, Librach CL, Jaffe RB. Localization and regulation of the activin-A dimer in human placental cells. J Clin Endocrinol Metab. 1992;75:571-576.
40. Leto G, Incorvaia L, Badalamenti G, et al. Activin A circulating levels in patients with bone metastasis from breast or prostate cancer. Clin Exp Metastasis. 2006;23:117-122. (Pubitemid 44440171)
41. Shurin GV, Ferris RL, Tourkova IL, et al. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. J Immunol. 2005;174:5490-5498.
42. Zlotnik A. Chemokines and cancer. Int J Cancer. 2006;119:2026-2029.
43. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. 2004;4:540-550.